Suchergebnisse - (Person:"Shen, Liang")

PubPharm (12)

1

Combination Therapy and Dual-Target Inhibitors Based on LSD1 : New Emerging Tools in Cancer Therapy

enthalten in: Journal of medicinal chemistry | 2024

von Shen, L. | Wang, B. | Wang, S. | +6

2

Novel acridine-based LSD1 inhibitors enhance immune response in gastric cancer

enthalten in: European journal of medicinal chemistry | 2023

von Dai, X. | Liu, Y. | Wang, N. | +10

3

Combination of FAK inhibitor and cytokine-induced killer cell therapy : An alternative therapeutic strategy for patients with triple-negative breast cancer

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von Wu, C. | Pan, M. | Shih, S. | +7

4

Hsa-miR-4271 downregulates the expression of constitutive androstane receptor and enhances in vivo the sensitivity of non-small cell lung cancer to gefitinib

enthalten in: Pharmacological research | 2020

von Wang, C. | Ding, S. | Sun, B. | +4

5

Design, syntheses and evaluations of novel indole derivatives as orally selective estrogen receptor degraders (SERD)

enthalten in: Bioorganic & medicinal chemistry letters | 2020

von Dong, J. | Wang, T. | Lu, J. | +14

6

Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients

enthalten in: Brachytherapy | 2017

von Koh, V. | Choo, B. | Lee, K. | +6

7

Michael acceptor in gambogic acid--Its role and application for potent antitumor agents

enthalten in: Bioorganic & medicinal chemistry letters | 2015

von Wang, J. | Shen, W. | Yuan, Z. | +16

8

Inhibitory effects of STAT3 decoy oligodeoxynucleotides on human epithelial ovarian cancer cell growth in vivo

enthalten in: International journal of molecular medicine | 2013

von Zhang, X. | Liu, P. | Zhang, B. | +3

9

3-Deazaneplanocin A is a promising therapeutic agent for ovarian cancer cells

enthalten in: Asian Pacific journal of cancer prevention : APJCP | 2013

von Shen, L. | Cui, J. | Pang, Y. | +2

10

Association of expression of XIAP-associated factor 1 (XAF1) with clinicopathologic factors, overall survival, microvessel density and cisplatin-resistance in ovarian cancer

enthalten in: Regulatory peptides | 2012

von Wang, Y. | Mao, H. | Hao, Q. | +5